The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Avidity Biosciences, Inc(NASDAQ:RNA) 
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment...
Website: http://www.aviditybiosciences.com
Founded: 2012
CEO: Sarah Boyce
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Avidity Biosciences Days Payable Outstanding ttm (DPO)
Avidity Biosciences Days Receivable Outstanding ttm (DSO)
Avidity Biosciences Days Inventory Outstanding ttm (DIO)
Avidity Biosciences Op Cashflow Per Share ttm
Avidity Biosciences Free Cashflow Per Share ttm
Avidity Biosciences Cash Per Share ttm
Avidity Biosciences P/S ratio ttm
Avidity Biosciences (GAAP) P/E ratio ttm
Avidity Biosciences P/B ratio ttm
No extra charts and metrics for this ticker.